The Field of Synthetic Biology Runs on Speculative Fiction
By Jason Koebler,
VICE Motherboard
| 11. 18. 2016
Gene editing and new biological engineering techniques have allowed our minds to run wild: In the last few years, we’ve seen proposals to build North Face jackets out of synthesized spider silk, grow human organs within pigs for transplantation, de-extinctlong dead animals, and use animal-human “hybrid organs” to prevent or treat disease. We’ve seen projects proposing leather made from humans, lab-grown, cruelty-free meat, and have begun to grapple with a future that might include both real dragons and DIY pathogens cooked up in someone’s basement.
Biofabricate, a synthetic biology conference held in Manhattan on Thursday, began with the message that journalists must be careful not to sensationalize an art project that used real science to look at whether it’d one day be possible for a human woman to give birth to an endangered dolphin.
“I think it’s very important to get projects like this out into mainstream press, but then you have clickbait, and these projects lend themselves to sensationalization,” Anthony Dunne, a professor of design and emerging technology at Parsons, told the crowd...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...